Ricardo Alonso-Zaldivar

Associated Press
Latest in Operations
The Hidden Costs of Standing Still
Sponsored
The Hidden Costs of Standing Still
September 2, 2026
Ev Battery
A $5 Billion Opportunity: The Case for Composite EV Battery Enclosures
August 31, 2026
Ep597
Stanley Black & Decker to Close Maryland Tool Factory
September 2, 2026
Eaton is expanding its U.S. manufacturing footprint with a state-of-the-art manufacturing facility in North Little Rock, Arkansas.
Eaton to Build $242M Manufacturing Facility in Arkansas to Expand Newly Acquired Custom Electrical Enclosure Business
September 2, 2026
Related Stories
Meltric Thumb 5751d02482349
Operations
Quick Motor Changeouts
A horizontal drilling well in the Marcellus Shale.
Operations
Shell Building Ethane Plant
Barra 5756dcee381e7
Operations
GM CEO Sticks to Strategy
Beyond the Dashboard
Sponsor Content
Beyond the Dashboard
More from Ricardo Alonso-Zaldivar
The Hidden Costs of Standing Still
Sponsored
The Hidden Costs of Standing Still
Why delaying ERP modernization is riskier than you think.
September 2, 2026
President Donald Trump listens as Secretary of Health and Human Services Alex Azar speaks during a briefing on the coronavirus at the National Institutes of Health, Tuesday, March 3, 2020, in Bethesda, Md.
Software
New Health Care Tech Rules
The rules are intended to get at one of the major problems with electronic health records.
March 9, 2020
In this June 15, 2018 file photo, pharmaceuticals are seen in North Andover, MA.
Regulation
Drug Cost Legislation Gets Push from White House
President Trump is backing a compromise bill in the Senate that doesn't give Medicare bargaining authority, but forces drugmakers to pay rebates if they raise prices too high.
November 18, 2019
Speaker of the House Nancy Pelosi, D-Calif., arrives for a closed-door meeting with the House Democratic Caucus, Wednesday, Sept. 18, 2019, at the Capitol in Washington.
Regulation
Proposed Plan Would Cut Drug Prices
The bill would allow Medicare to negotiate with drug companies and cap the out of pocket costs for seniors.
September 20, 2019
In this Tuesday, July 16, 2019, file photo, Health and Human Services Secretary Alex Azar pauses while speaking during a Cabinet meeting at the White House, in Washington. Azar says he and President Donald Trump are working on a plan to allow Americans to import lower-priced prescription drugs from Canada.
Supply Chain
Plan Allows Prescription Drugs from Canada
Consumer groups have strongly backed the idea, arguing that it will pressure U.S. drugmakers to reduce their prices.
July 31, 2019
In this June 15, 2018 photo, pharmaceuticals are seen in North Andover, Mass. A prescription drug compromise that would lower costs for Medicare recipients has cleared a key hurdle in the Senate, but Republican resistance signals trouble when the legislation goes to the floor.
Regulation
Drug Pricing Bill Advances for Now
The bill would for the first time limit out-of-pocket costs medication costs faced by seniors to $3,100.
July 26, 2019
President Donald Trump speaks about kidney health at the Ronald Reagan Building and International Trade Center, accompanied by Health and Human Services Secretary Alex Azar, left, Wednesday, July 10, 2019, in Washington.
Regulation
White House Yanks Drug 'Rebate' Plan
It looks like a defeat for the pharmaceutical industry, which preferred the consumer rebate approach to other ideas that lawmakers are considering.
July 11, 2019
In this Oct. 25, 2018, file photo, President Donald Trump talks about drug prices during a visit to the Department of Health and Human Services in Washington. A federal judge Monday, July 8, 2019, blocked a major White House initiative on prescription drug costs, saying the Trump administration lacked the legal authority to require drugmakers to disclose their prices in TV ads.
Regulation
Drug Ads Won't Have to Reveal Prices
Drugmakers had argued that requiring them to disclose list prices amounted to coercion that would violate their free speech rights under the Constitution.
July 9, 2019
President Donald Trump speaks during a event on medical billing, in the Roosevelt Room of the White House, Thursday, May 9, 2019, in Washington.
Supply Chain
Trump Backs Plan to Import Meds
The bill overcame stiff opposition from pharmaceutical companies who claimed importing drugs would lead to risks of counterfeit substances.
May 10, 2019
In this March 13, 2019, file phtooHealth and Human Services Secretary Alex Azar testifies before a House Appropriations subcommittee on Capitol Hill in Washington. Azar says drugmakers will soon have to reveal prices of their prescription medicines in those ever-present TV ads. The Trump administration will issue final regulations on May 8 requiring drug companies to disclose list prices of medications costing more than $35 for a month’s supply. Azar tells The Associated Press if drugmakers are scared to put prices in ads that means they should lower those prices.
Regulation
Drugmakers Will Have to Reveal Prices
The pricing details are expected to appear in text toward the end of commercials, when potential side effects are being disclosed.
May 8, 2019
Medicare
Regulation
Feds Bust $1.2B Brace Scam
Doctors, telemedicine firms and medical equipment companies were among those charged.
April 9, 2019
Sen. Chuck Grassley, R-Iowa, chairman of the Senate Finance Committee, attends a hearing on drug prices, Tuesday, Feb. 26, 2019 on Capitol Hill in Washington.
Regulation
Senators Grill Pharma Execs
Some of the companies initially had sought a private meeting, but lawmakers refused and insisted the CEOs appear in public or risk subpoenas.
February 26, 2019
President Donald Trump talks about drug prices during a visit to the Department of Health and Human Services in Washington, Thursday, Oct. 25, 2018.
Regulation
Trump Squares Off with Drugmakers
Drugmakers immediately protested, arguing the plan amounts to government price-setting.
October 29, 2018
Medicare Prescription Costs Ap 57641effa4b80
Regulation
Drug Costs Prompt Call for Medicare Changes
The recommendations are unlikely to gain traction in Congress during an election year, but they will get a serious look from staff experts on key House and Senate committees overseeing Medicare.
June 17, 2016
This Oct. 14, 2015, file photo, shows the Food & Drug Administration campus in Silver Spring, Md. Despite new legal powers to compel recalls and sophisticated technology to fingerprint pathogens, the Food and Drug Administration allowed some food-safety investigations to drag on, placing consumers in jeopardy of death or serious illness, according to the inspector general’s office at the Department of Health and Human Services.
Regulation
FDA Still Taking Months to Recall Tainted Food
Watchdog says FDA needs to pay 'immediate attention to the problem and get manufacturers to promptly recall tainted foods.
June 9, 2016